retatrutide phase 2 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Does Retatrutide Make You Lose

In a 48-week phase II clinical trial conducted on patients with type 2 diabetes and obesity, treatment with a dose of 10 mg/kg of bimagrumab resulted in a significant reduction in fat mass by 20.5% (compared to 0.5% in the placebo group), while lean body mass increased by 3.6% (as opposed to a decrease of 0.8% in the placebo group), leading to an overall body weight reduction of -6.5%, which was substantially better than the -0.8% observed in the placebo group

Long-term inflammation is linked to: Type 2 diabetes Heart disease Fatty liver (NAFLD/NASH) Obesity Autoimmune and gut disorders Experts believe metabolic inflammation is a root cause of insulin resistance and poor cardiovascular outcomes

Supplied for laboratory research use only

Every 0.1 mL (10 units) equals exactly 100 mcg

During your video visit, we will: Review your health history Discuss your goals Answer all of your questions Determine if GLP-1 therapy is right for you Customize your treatment plan All from the comfort of your home